HSBC Global Research kept a 'Buy' rating on the stock with a target price Rs 550. PL Capital maintained a 'Buy' rating on Aster DM Healthcare Ltd. and raised the target price to Rs 620 from Rs 500.

Aster DM Quality Care Limited is set to merge with four prominent healthcare brands, including Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare. The combined entity will emerge as one of the top three hospital chains in the country.

Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals

CNBC-TV18 had reported on August 4 this year about the discussions between the two companies, aimed at expanding Aster DM’s hospital network.

The merged entity, Aster DM Quality Care Limited, will have a combined portfolio of four leading brands: Aster DM, CARE Hospitals, KIMSHEALTH and Evercare. It will have a of network of 38 hospitals and 10,

The combined entity will have a portfolio of brands, including Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare.

Alisha says ₹43,000 crore enterprise-valued merger deal is among the biggest healthcare transactions this year in the world in the space of healthcare delivery.

Aster DM Healthcare and Blackstone-owned QCIL have agreed to merge, forming Aster DM Quality Care Limited. Blackstone will hold roughly 30.7% of the merged entity, valued at ₹42,000 crore. The deal, expected to close by Q3 FY26,

Based on the swap ratio recommended in the valuation report, the Aster promoters will hold 24 per cent and Blackstone 30.7 per cent in the merged entity

In the merged entity, Aster promoters and Blackstone will hold 24% and 30.7% stakes, respectively, while the balance 45.3% will be owned by other shareholders.